Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.
about
Role of HLA Adaptation in HIV EvolutionIdentification of a cluster of HIV-1 controllers infected with low replicating virusesIdentification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected IndividualsAssociation of single nucleotide polymorphisms in the lens epithelium-derived growth factor (LEDGF/p75) with HIV-1 infection outcomes in Brazilian HIV-1+ individualsA correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllersLow-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controllerNo evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors.Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllersModest attenuation of HIV-1 Vpu alleles derived from elite controller plasmaScreening of the Pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors.Immune-mediated attenuation of HIV-1Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American EpidemicHost factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular CytotoxicityHIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacityElevated hypermutation levels in HIV-1 natural viral suppressors.Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.HIV-1 replicative fitness in elite controllers.The implications of viral reservoirs on the elite control of HIV-1 infection.HIV controllers: a genetically determined or inducible phenotype?Unravelling the mechanisms of durable control of HIV-1.Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control.Novel Acylguanidine-Based Inhibitor of HIV-1.Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.Pairwise growth competition assay for determining the replication fitness of human immunodeficiency viruses.Attenuation of multiple Nef functions in HIV-1 elite controllers.Impaired Nef function is associated with early control of HIV-1 viremia.Association of the HLA-B*52 allele with non-progression to AIDS in Brazilian HIV-1-infected individuals.What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.Understanding the CD8 T-cell response in natural HIV controlPol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection
P2860
Q26772713-23E43607-82DB-4D92-BFF5-91FA93E2B61AQ28534737-354C91C4-A46B-439F-B5AF-AFB9517DC93FQ28552777-A4F5A45E-A59A-4783-BDA5-FB8E24B3B783Q33928605-DAFB65EC-27CF-4E56-BEBF-68723086FAFCQ33982102-37E1E54F-92D8-49CD-BA27-4BE3EDD54CC1Q34182086-F4C1DFEE-B514-4851-9A3B-810E822BCC9EQ34981309-E7048293-2F58-445D-A19C-193E01FF4C60Q35216907-3540D9E6-C471-461E-B965-37DD8426AEE5Q35489088-9D3C467E-E9F1-4607-BDFC-32E9D751DF99Q35582429-3CB7CE77-5892-440B-BB52-434A9B63D2E4Q35591789-BCB6698B-59D5-43BA-9600-11BE282A7B5CQ35798108-8F1B578D-EC4C-4258-9EB7-D97271EA7D36Q36086711-0F1CB486-68CE-441E-98A6-6D2FF7E8AE5EQ36281754-22E5D014-8C6F-4D6B-B797-C356884603B0Q36301732-9F2AE6C3-61BF-461D-BBFF-71C388AE06A7Q36414578-FA0228BE-1DA3-42BF-AEB6-FF8FB1BFC8CEQ36481449-0DDD5F66-B23D-4C31-98AE-0E605AE0E907Q36547178-56965D6B-52B4-422E-9E77-79ABF60C15AAQ36736588-709B89C8-13D9-4CF0-8F86-C9D0B77135C7Q36827382-3DA99534-44A1-4EB1-99F5-C519105DE451Q37145307-98B7CDBA-7748-466F-A541-43D7E64F7749Q37260482-03D3BB0E-096C-458E-AC39-F9E25F96B13FQ37643772-93525368-E50E-4EE0-A61E-9EF9497AAE76Q37713470-AB2E67F4-F0C1-4564-B02A-6C3526B2BE52Q37856676-EC0B1304-1AFF-4F19-AE09-8E47CEB7613FQ38032153-02662879-85E8-4045-98A0-AD11A4CD53C6Q38114915-DAB7E5B7-F466-46BC-A601-B72902919D6EQ38116710-B63D1DD4-6045-4883-BC1F-67AD9373278CQ38725490-E86D2D1F-56DA-4061-A2B1-A8824DD6E9ABQ38737586-6B7F2919-56C4-4D80-A244-05B2A2C3ED0EQ38752518-11C917B4-F482-46E4-97EC-3B2545328CA8Q40428899-50F9D088-8B5C-4E84-9B2C-809E9777EEC3Q41213664-54E8BBC4-787C-48D8-BDBA-132D815D1AADQ41868799-66B9E363-5A33-4151-8EA9-F15B8DE22B11Q42208915-10BEA13F-ECBB-449B-A3E7-6D3E333C4BEBQ42225751-11CC87DA-C044-48A6-B6DF-08FA4C4D4A73Q47561102-06B4D0D8-284D-4C1B-805F-43A6DC387983Q57177414-835D44A8-2663-43F1-BE9B-0E5EE96B2571Q57206384-047DBAA8-140D-41D5-8CC1-A7E5C97F547B
P2860
Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Reduced replication capacity o ...... from HIV-1 elite controllers.
@en
Reduced replication capacity o ...... from HIV-1 elite controllers.
@nl
type
label
Reduced replication capacity o ...... from HIV-1 elite controllers.
@en
Reduced replication capacity o ...... from HIV-1 elite controllers.
@nl
prefLabel
Reduced replication capacity o ...... from HIV-1 elite controllers.
@en
Reduced replication capacity o ...... from HIV-1 elite controllers.
@nl
P2093
P2860
P50
P1476
Reduced replication capacity o ...... from HIV-1 elite controllers.
@en
P2093
Brian L Block
Carl M Kadie
Eric Martin
Jennifer Sela
Pamela C Rosato
Toshiyuki Miura
Tristan J Markle
P2860
P304
P356
10.1097/QAI.0B013E3181FE9450
P407
P50
P577
2011-02-01T00:00:00Z